Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors

Xiaomei Chen; Li Ding; Yuan Tao; Christophe Pannecouque; De Clercq Erik; Chunlin Zhuang; Fen‐Er Chen

doi:10.1016/j.ejmech.2020.112549

Back

Shared by

De Clercq Erik

KU Leuven

Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors

Article 2020 en

Authors

XC
Xiaomei Chen
LD
Li Ding
YT
Yuan Tao

Related publications

Article2023

Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors

Xiangyi Jiang, Boshi Huang, Shawn Rumrill, David Pople, Waleed A. Zalloum, Dongwei Kang, Fabao Zhao, Xiangkai Ji, Zhen Gao, Lide Hu, Zhao Wang, Minghui Xie, De Clercq Erik, Francesc X. Ruiz, Eddy Arnold, Christophe Pannecouque, Xinyong Liu, Peng Zhan

Article2012

Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors

Shuang‐Xi Gu, Zhiming Li, Xiaodong Ma, Shiqiong Yang, Qiuqin He, Fen‐Er Chen, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Article2019

Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors

Kaijun Jin, Minjie Liu, Chunlin Zhuang, De Clercq Erik, Christophe Pannecouque, Ge Meng, Fen‐Er Chen

Article2025

Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Zhenzhen Zhou, Jie Guo, Xin Li, Jinyuan Wu, De Clercq Erik, Christophe Pannecouque, Peng Zhan, Dongwei Kang, Xinyong Liu

Article2014

Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors

Shuang‐Xi Gu, Yuan‐Yuan Zhu, Fen‐Er Chen, De Clercq Erik, Jan Balzarini, Christophe Pannecouque

Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors

Discussion(0)

Related publications

Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors

Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors

Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors

Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Structural modification of diarylpyrimidine derivatives as HIV-1 reverse transcriptase inhibitors